Last 12 months
Inside the activity.
0 purchase rows · 4 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 15, 2023 Filed Jun 20, 2023 20:30 UTC |
Nova Tina SusanDirector · Executive Chairperson
|
GrantStock Option(right to buy) · Derivative | 13,500 | $0.00 Strike: $3.22 | $0.00 |
DisclosureSEC source: 0001274737-23-000069 · wf-form4_168729301301351.xml · derivative · entry 1 Nova Tina Susan · CIK 0001302605 · Director · Executive Chairperson 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,500 Underlying: Common Stock · 13,500 shares Expires 2033-06-14 F1 · derivative.exercise_date: The entire number of shares subject to this option becomes fully vested and exercisable on the earlier of June 9, 2024 or the date of the Issuer's 2024 Annual Meeting of Stockholders, subject to the Reporting Person's continued service to the Issuer through such vesting date. Read SEC document |
| June 15, 2023 Filed Jun 20, 2023 21:04 UTC |
TULLIS JAMES L L10% owner
TULLIS GROWTH FUND II, L.P.10% owner
|
PurchaseCommon Stock | 167 | $3.11 | $519.45 |
DisclosureSEC source: 0000899243-23-015986 · doc4.xml · nonDerivative · entry 1 TULLIS JAMES L L · CIK 0001230641 · 10% owner TULLIS GROWTH FUND II, L.P. · CIK 0001746842 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 1,515,839 F1 · kind: The transaction reported herein was effected by Tullis Growth Fund II, L.P. ("Tullis Growth II"). F2 · ownership.nature: The shares reported on this form are held of record by Tullis-Dickerson Capital Focus III, L.P. ("Tullis"), Tullis Growth Fund, L.P. ("Tullis Growth") and Tullis Growth II. Tullis-Dickerson Partners III, LLC ("Tullis Partners") is the general partner of Tullis and may be deemed to beneficially own the securities held by Tullis. Tullis Growth Partners, LLC and Tullis Growth Partners II, LLC are the general partners of Tullis Growth and Tullis Growth II, respectively, and may be deemed to beneficially own the securities held by Tullis Growth and Tullis Growth II. James L.L. Tullis is a Principal of each of the foregoing entities and may be deemed to possess voting and investment control over, and may be deemed to have an indirect beneficial ownership with respect to, the shares held by Tullis, Tullis Growth and Tullis Growth II. Read SEC document |
| June 09, 2023 Filed Jun 13, 2023 16:35 UTC |
Johnson Wendy S.Director
|
GrantStock Option(right to buy) · Derivative | 9,000 | $0.00 Strike: $3.13 | $0.00 |
DisclosureSEC source: 0001274737-23-000060 · wf-form4_168668852605535.xml · derivative · entry 1 Johnson Wendy S. · CIK 0001652822 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,000 Underlying: Common Stock · 9,000 shares Expires 2033-06-08 F1 · derivative.exercise_date: The entire number of shares subject to this option becomes fully vested and exercisable on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date. Read SEC document |
| June 09, 2023 Filed Jun 13, 2023 20:36 UTC |
Stokes FrankDirector
|
GrantStock Option(right to buy) · Derivative | 9,000 | $0.00 Strike: $3.13 | $0.00 |
DisclosureSEC source: 0001274737-23-000064 · wf-form4_168668859227831.xml · derivative · entry 1 Stokes Frank · CIK 0001782815 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,000 Underlying: Common Stock · 9,000 shares Expires 2033-06-08 F1 · derivative.exercise_date: The entire number of shares subject to this option becomes fully vested and exercisable on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date. Read SEC document |
| June 09, 2023 Filed Jun 13, 2023 20:36 UTC |
Birk BrianDirector
|
GrantStock Option(right to buy) · Derivative | 9,000 | $0.00 Strike: $3.13 | $0.00 |
DisclosureSEC source: 0001274737-23-000063 · wf-form4_168668857704156.xml · derivative · entry 1 Birk Brian · CIK 0001616007 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,000 Underlying: Common Stock · 9,000 shares Expires 2033-06-08 F1 · derivative.exercise_date: The entire number of shares subject to this option becomes fully vested and exercisable on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date. Read SEC document |
| June 09, 2023 Filed Jun 13, 2023 20:36 UTC |
PALLARES EBETUELDirector
|
GrantStock Option(right to buy) · Derivative | 9,000 | $0.00 Strike: $3.13 | $0.00 |
DisclosureSEC source: 0001274737-23-000062 · wf-form4_168668855957603.xml · derivative · entry 1 PALLARES EBETUEL · CIK 0001614597 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,000 Underlying: Common Stock · 9,000 shares Expires 2023-06-08 F1 · derivative.exercise_date: The entire number of shares subject to this option becomes fully vested and exercisable on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date. Read SEC document |
| June 09, 2023 Filed Jun 13, 2023 20:35 UTC |
Hooker AnaDirector
|
GrantStock Option(right to buy) · Derivative | 9,000 | $0.00 Strike: $3.13 | $0.00 |
DisclosureSEC source: 0001274737-23-000061 · wf-form4_168668854264707.xml · derivative · entry 1 Hooker Ana · CIK 0001774825 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,000 Underlying: Common Stock · 9,000 shares Expires 2033-06-08 F1 · derivative.exercise_date: The entire number of shares subject to this option becomes fully vested and exercisable on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 16:37 UTC |
Hazeltine MarkChief Business Officer
|
SaleCommon Stock | 3,667 | $0.00 | $0.00 |
DisclosureSEC source: 0001274737-23-000013 · wf-form4_167787940835174.xml · nonDerivative · entry 1 Hazeltine Mark · CIK 0001852986 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 190,205 F1 · shares: The shares were sold by the reporting person to generate proceeds used to satisfy the tax withholding obligation that arose upon the vesting of certain restricted stock units granted to the reporting person on February 23, 2021. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 21:38 UTC |
Adawi KamalCFO and Corporate Secretary
|
SaleCommon Stock | 3,667 | $2.30 | $8,431.53 |
DisclosureSEC source: 0001274737-23-000014 · wf-form4_167787945297244.xml · nonDerivative · entry 1 Adawi Kamal · CIK 0001788393 · CFO and Corporate Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 188,271 F1 · shares: The shares were sold by the reporting person to generate proceeds used to satisfy the tax withholding obligation that arose upon the vesting of certain restricted stock units granted to the reporting person on February 23, 2021. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 16:06 UTC |
Hazeltine MarkChief Business Officer
|
GrantCommon Stock | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001274737-23-000011 · wf-form4_167770470514707.xml · nonDerivative · entry 1 Hazeltine Mark · CIK 0001852986 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 193,872 F1 · shares: Represents 100,000 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units will vest with respect to 25% of the restricted stock units on each of the first, second, third and fourth anniversaries of March 1, 2023, subject to the Reporting Person's continued service through the applicable vesting date. In addition, the award may become fully vested upon a qualifying termination of employment in accordance with the Company's Amended and Restated Executive Change in Control Severance Plan, as the same may be amended from time to time. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 21:06 UTC |
Adawi KamalCFO and Corporate Secretary
|
GrantCommon Stock | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001274737-23-000012 · wf-form4_167770478495929.xml · nonDerivative · entry 1 Adawi Kamal · CIK 0001788393 · CFO and Corporate Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 191,938 F1 · shares: Represents 100,000 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units will vest with respect to 25% of the restricted stock units on each of the first, second, third and fourth anniversaries of March 1, 2023, subject to the Reporting Person's continued service through the applicable vesting date. In addition, the award may become fully vested upon a qualifying termination of employment in accordance with the Company's Amended and Restated Executive Change in Control Severance Plan, as the same may be amended from time to time. Read SEC document |
| February 08, 2023 Filed Feb 10, 2023 16:08 UTC |
Hazeltine MarkChief Business Officer
|
SaleCommon Stock | 5,821 | $2.69 | $15,672.46 |
DisclosureSEC source: 0001274737-23-000008 · wf-form4_167606330014830.xml · nonDerivative · entry 1 Hazeltine Mark · CIK 0001852986 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,872 F1 · shares: The shares were sold by the reporting person to generate proceeds used to satisfy the tax withholding obligation that arose upon the vesting of certain restricted stock units granted to the reporting person on February 4, 2022. Read SEC document |
| February 08, 2023 Filed Feb 10, 2023 21:05 UTC |
Adawi KamalCFO and Corporate Secretary
|
SaleCommon Stock | 5,821 | $2.69 | $15,670.71 |
DisclosureSEC source: 0001274737-23-000007 · wf-form4_167606311295012.xml · nonDerivative · entry 1 Adawi Kamal · CIK 0001788393 · CFO and Corporate Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,938 F1 · shares: The shares were sold by the reporting person to generate proceeds used to satisfy the tax withholding obligation that arose upon the vesting of certain restricted stock units granted to the reporting person on February 4, 2022. Read SEC document |
| December 08, 2022 Filed Dec 9, 2022 14:00 UTC |
ABALLI JOHNDirector · President and CEO
|
PurchaseCommon Stock | 90,000 | $2.68 | $241,200.00 |
DisclosureSEC source: 0001274737-22-000083 · wf-form4_167059440451764.xml · nonDerivative · entry 1 ABALLI JOHN · CIK 0001843113 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 440,000 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.34 to $2.75, inclusive. The reporting person undertakes to provide Exagen Inc., any security holder of Exagen Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this form 4. Read SEC document |
| October 16, 2022 Filed Oct 19, 2022 00:38 UTC |
ABALLI JOHNDirector · President and CEO
|
GrantRestricted Stock Units | 350,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001843113-22-000010 · wf-form4_166613985172902.xml · nonDerivative · entry 1 ABALLI JOHN · CIK 0001843113 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 350,000 F1 · shares: The securities awarded are in the form of restricted stock units under the issuer's 2019 Incentive Award Plan. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock unit will vest with respect to 25% of the restricted stock units on each of the first, second, third and fourth anniversaries of October 16, 2022, subject to the Reporting Person's continued service through the applicable vesting date. In addition, the award may become fully vested upon a qualifying termination of employment in connection with a change in control. Read SEC document |
| June 16, 2022 Filed Jun 21, 2022 08:34 UTC |
Johnson Wendy S.Director
|
GrantStock Option(right to buy) · Derivative | 9,000 | $0.00 Strike: $5.25 | $0.00 |
DisclosureSEC source: 0001274737-22-000046 · wf-form4_165581482752855.xml · derivative · entry 1 Johnson Wendy S. · CIK 0001652822 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,000 Underlying: Common Stock · 9,000 shares Expires 2032-06-15 F1 · derivative.exercise_date: The entire number of shares subject to this option becomes fully vested and exercisable on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date. Read SEC document |
| June 16, 2022 Filed Jun 21, 2022 12:33 UTC |
Nova Tina SusanDirector
|
GrantStock Option(right to buy) · Derivative | 9,000 | $0.00 Strike: $5.25 | $0.00 |
DisclosureSEC source: 0001274737-22-000044 · wf-form4_165581479360117.xml · derivative · entry 1 Nova Tina Susan · CIK 0001302605 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,000 Underlying: Common Stock · 9,000 shares Expires 2032-06-15 F1 · derivative.exercise_date: The entire number of shares subject to this option becomes fully vested and exercisable on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date. Read SEC document |
| June 16, 2022 Filed Jun 21, 2022 12:33 UTC |
TULLIS JAMES L LDirector · 10% owner
|
GrantStock Option(right to buy) · Derivative | 9,000 | $0.00 Strike: $5.25 | $0.00 |
DisclosureSEC source: 0001274737-22-000043 · wf-form4_165581477536403.xml · derivative · entry 1 TULLIS JAMES L L · CIK 0001230641 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,000 Underlying: Common Stock · 9,000 shares Expires 2032-06-15 F1 · derivative.exercise_date: The entire number of shares subject to this option becomes fully vested and exercisable on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date. Read SEC document |
| June 16, 2022 Filed Jun 21, 2022 12:33 UTC |
PALLARES EBETUELDirector
|
GrantStock Option(right to buy) · Derivative | 9,000 | $0.00 Strike: $5.25 | $0.00 |
DisclosureSEC source: 0001274737-22-000045 · wf-form4_165581481042927.xml · derivative · entry 1 PALLARES EBETUEL · CIK 0001614597 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,000 Underlying: Common Stock · 9,000 shares Expires 2032-06-15 F1 · derivative.exercise_date: The entire number of shares subject to this option becomes fully vested and exercisable on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date. Read SEC document |
| June 16, 2022 Filed Jun 21, 2022 12:32 UTC |
Hooker AnaDirector
|
GrantStock Option(right to buy) · Derivative | 9,000 | $0.00 Strike: $5.25 | $0.00 |
DisclosureSEC source: 0001274737-22-000042 · wf-form4_165581475880300.xml · derivative · entry 1 Hooker Ana · CIK 0001774825 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,000 Underlying: Common Stock · 9,000 shares Expires 2032-06-15 F1 · derivative.exercise_date: The entire number of shares subject to this option becomes fully vested and exercisable on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date. Read SEC document |
| June 16, 2022 Filed Jun 21, 2022 12:32 UTC |
Birk BrianDirector
|
GrantStock Option(right to buy) · Derivative | 9,000 | $0.00 Strike: $5.25 | $0.00 |
DisclosureSEC source: 0001274737-22-000041 · wf-form4_165581473943886.xml · derivative · entry 1 Birk Brian · CIK 0001616007 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,000 Underlying: Common Stock · 9,000 shares Expires 2032-06-15 F1 · derivative.exercise_date: The entire number of shares subject to this option becomes fully vested and exercisable on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date. Read SEC document |
| June 16, 2022 Filed Jun 21, 2022 12:32 UTC |
Stokes FrankDirector
|
GrantStock Option(right to buy) · Derivative | 9,000 | $0.00 Strike: $5.25 | $0.00 |
DisclosureSEC source: 0001274737-22-000040 · wf-form4_165581472086924.xml · derivative · entry 1 Stokes Frank · CIK 0001782815 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,000 Underlying: Common Stock · 9,000 shares Expires 2032-06-15 F1 · derivative.exercise_date: The entire number of shares subject to this option becomes fully vested and exercisable on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 16:40 UTC |
Hazeltine MarkChief Operating Officer
|
Tax withholdingCommon Stock | 3,241 | $7.12 | $23,075.92 |
DisclosureSEC source: 0001274737-22-000018 · wf-form4_164625718287172.xml · nonDerivative · entry 1 Hazeltine Mark · CIK 0001852986 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,693 F1 · shares: The shares were withheld from the Reporting Person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted on February 23, 2021. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 21:41 UTC |
Zack DebraChief Medical Officer
|
Tax withholdingCommon Stock | 3,241 | $7.12 | $23,075.92 |
DisclosureSEC source: 0001274737-22-000019 · wf-form4_164625724694463.xml · nonDerivative · entry 1 Zack Debra · CIK 0001807743 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,259 F1 · shares: The shares were withheld from the Reporting Person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted on February 23, 2021. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 21:37 UTC |
Rocca Fortunato R.Director · President and CEO
|
Tax withholdingCommon Stock | 4,322 | $7.12 | $30,772.64 |
DisclosureSEC source: 0001274737-22-000016 · wf-form4_164625703760601.xml · nonDerivative · entry 1 Rocca Fortunato R. · CIK 0001492734 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,678 F1 · shares: The shares were withheld from the Reporting Person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted on February 23, 2021. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 21:39 UTC |
Adawi KamalCFO and Corporate Secretary
|
Tax withholdingCommon Stock | 3,241 | $7.12 | $23,075.92 |
DisclosureSEC source: 0001274737-22-000017 · wf-form4_164625710800777.xml · nonDerivative · entry 1 Adawi Kamal · CIK 0001788393 · CFO and Corporate Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,759 F1 · shares: The shares were withheld from the Reporting Person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted on February 23, 2021. Read SEC document |
| February 04, 2022 Filed Feb 8, 2022 16:21 UTC |
Hazeltine MarkChief Operating Officer
|
GrantCommon Stock | 63,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001274737-22-000010 · wf-form4_164435529026997.xml · nonDerivative · entry 1 Hazeltine Mark · CIK 0001852986 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,934 F1 · shares: Represents 63,500 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock unit will vest with respect to 25% of the restricted stock units on each of the first, second, third and fourth anniversaries of February 4, 2022, subject to the Reporting Person's continued service through the applicable vesting date. In addition, the award may become fully vested upon a qualifying termination of employment in connection with a change in control. F2 · balance_after: Represents 63,500 shares of restricted stock units granted on February 4, 2022, 37,500 shares of restricted stock units granted on February 23, 2021 and 1,934 shares of common stock. Read SEC document |
| February 04, 2022 Filed Feb 8, 2022 21:23 UTC |
Zack DebraChief Medical Officer
|
GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001274737-22-000011 · wf-form4_164435534136243.xml · nonDerivative · entry 1 Zack Debra · CIK 0001807743 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,500 F1 · shares: Represents 50,000 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock unit will vest with respect to 25% of the restricted stock units on each of the first, second, third and fourth anniversaries of February 4, 2022, subject to the Reporting Person's continued service through the applicable vesting date. In addition, the award may become fully vested upon a qualifying termination of employment in connection with a change in control. F2 · balance_after: Represents 50,000 shares of restricted stock units granted on February 4, 2022 and 37,500 shares of restricted stock units granted on February 23, 2021. Read SEC document |
| February 04, 2022 Filed Feb 8, 2022 21:19 UTC |
Rocca Fortunato R.Director · President and CEO
|
GrantCommon Stock | 75,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001274737-22-000008 · wf-form4_164435515279183.xml · nonDerivative · entry 1 Rocca Fortunato R. · CIK 0001492734 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 F1 · shares: Represents 75,000 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock unit will vest with respect to 25% of the restricted stock units on each of the first, second, third and fourth anniversaries of February 4, 2022, subject to the Reporting Person's continued service through the applicable vesting date. In addition, the award may become fully vested upon a qualifying termination of employment in connection with a change in control. F2 · balance_after: Represents 75,000 shares of restricted stock units granted on February 4, 2022 and 50,000 shares of restricted stock units granted on February 23, 2021. Read SEC document |
| February 04, 2022 Filed Feb 8, 2022 21:20 UTC |
Adawi KamalCFO and Corporate Secretary
|
GrantCommon Stock | 63,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001274737-22-000009 · wf-form4_164435521542460.xml · nonDerivative · entry 1 Adawi Kamal · CIK 0001788393 · CFO and Corporate Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,000 F1 · shares: Represents 63,500 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock unit will vest with respect to 25% of the restricted stock units on each of the first, second, third and fourth anniversaries of February 4, 2022, subject to the Reporting Person's continued service through the applicable vesting date. In addition, the award may become fully vested upon a qualifying termination of employment in connection with a change in control. F2 · balance_after: Represents 63,500 shares of restricted stock units granted on February 4, 2022 and 37,500 shares of restricted stock units granted on February 23, 2021. Read SEC document |
| September 03, 2021 Filed Sep 7, 2021 08:25 UTC |
Johnson Wendy S.Director
|
PurchaseCommon Stock | 1,000 | $14.02 | $14,020.00 |
DisclosureSEC source: 0001274737-21-000101 · wf-form4_163101751499196.xml · nonDerivative · entry 1 Johnson Wendy S. · CIK 0001652822 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 Read SEC document |
| August 05, 2021 Filed Aug 6, 2021 20:15 UTC |
TULLIS JAMES L LDirector
|
SaleCommon Stock | 6,800 | $10.72 | $72,862.68 |
DisclosureSEC source: 0000899243-21-031918 · doc4.xml · nonDerivative · entry 1 TULLIS JAMES L L · CIK 0001230641 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1,515,672 F1 · kind: These sales were effected by Tullis Growth Fund, L.P. ("Tullis Growth") pursuant to a Rule 10b5-1 trading plan adopted on March 24, 2021. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.47 to $11.40, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F3 · ownership.nature: The shares reported on this form are held of record by Tullis-Dickerson Capital Focus III, L.P. ("Tullis"), Tullis Growth and Tullis Growth Fund II, L.P. ("Tullis Growth II"). Tullis-Dickerson Partners III, LLC ("Tullis Partners") is the general partner of Tullis and may be deemed to beneficially own the securities held by Tullis. Tullis Growth Partners, LLC and Tullis Growth Partners II, LLC are the general partners of Tullis Growth and Tullis Growth II, respectively, and may be deemed to beneficially own the securities held by Tullis Growth and Tullis Growth II. James L.L. Tullis is a Principal of each of the foregoing entities and may be deemed to possess voting and investment control over, and may be deemed to have an indirect beneficial ownership with respect to, the shares held by Tullis, Tullis Growth and Tullis Growth II. Read SEC document |
| August 04, 2021 Filed Aug 4, 2021 22:29 UTC |
TULLIS JAMES L LDirector
|
SaleCommon Stock | 2,100 | $11.39 | $23,917.11 |
DisclosureSEC source: 0000899243-21-031644 · doc4.xml · nonDerivative · entry 3 TULLIS JAMES L L · CIK 0001230641 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1,522,472 F1 · kind: These sales were effected by Tullis Growth Fund, L.P. ("Tullis Growth") pursuant to a Rule 10b5-1 trading plan adopted on March 24, 2021. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.26 to $11.61, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F5 · ownership.nature: The shares reported on this form are held of record by Tullis-Dickerson Capital Focus III, L.P. ("Tullis"), Tullis Growth and Tullis Growth Fund II, L.P. ("Tullis Growth II"). Tullis-Dickerson Partners III, LLC ("Tullis Partners") is the general partner of Tullis and may be deemed to beneficially own the securities held by Tullis. Tullis Growth Partners, LLC and Tullis Growth Partners II, LLC are the general partners of Tullis Growth and Tullis Growth II, respectively, and may be deemed to beneficially own the securities held by Tullis Growth and Tullis Growth II. James L.L. Tullis is a Principal of each of the foregoing entities and may be deemed to possess voting and investment control over, and may be deemed to have an indirect beneficial ownership with respect to, the shares held by Tullis, Tullis Growth and Tullis Growth II. Read SEC document |
| August 03, 2021 Filed Aug 4, 2021 22:29 UTC |
TULLIS JAMES L LDirector
|
SaleCommon Stock | 4,300 | $11.77 | $50,617.88 |
DisclosureSEC source: 0000899243-21-031644 · doc4.xml · nonDerivative · entry 2 TULLIS JAMES L L · CIK 0001230641 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1,524,572 F1 · kind: These sales were effected by Tullis Growth Fund, L.P. ("Tullis Growth") pursuant to a Rule 10b5-1 trading plan adopted on March 24, 2021. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.65 to $12.07, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F5 · ownership.nature: The shares reported on this form are held of record by Tullis-Dickerson Capital Focus III, L.P. ("Tullis"), Tullis Growth and Tullis Growth Fund II, L.P. ("Tullis Growth II"). Tullis-Dickerson Partners III, LLC ("Tullis Partners") is the general partner of Tullis and may be deemed to beneficially own the securities held by Tullis. Tullis Growth Partners, LLC and Tullis Growth Partners II, LLC are the general partners of Tullis Growth and Tullis Growth II, respectively, and may be deemed to beneficially own the securities held by Tullis Growth and Tullis Growth II. James L.L. Tullis is a Principal of each of the foregoing entities and may be deemed to possess voting and investment control over, and may be deemed to have an indirect beneficial ownership with respect to, the shares held by Tullis, Tullis Growth and Tullis Growth II. Read SEC document |
| August 02, 2021 Filed Aug 4, 2021 22:29 UTC |
TULLIS JAMES L LDirector
|
SaleCommon Stock | 1,800 | $11.92 | $21,454.38 |
DisclosureSEC source: 0000899243-21-031644 · doc4.xml · nonDerivative · entry 1 TULLIS JAMES L L · CIK 0001230641 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1,528,872 F1 · kind: These sales were effected by Tullis Growth Fund, L.P. ("Tullis Growth") pursuant to a Rule 10b5-1 trading plan adopted on March 24, 2021. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.68 to $12.11, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F5 · ownership.nature: The shares reported on this form are held of record by Tullis-Dickerson Capital Focus III, L.P. ("Tullis"), Tullis Growth and Tullis Growth Fund II, L.P. ("Tullis Growth II"). Tullis-Dickerson Partners III, LLC ("Tullis Partners") is the general partner of Tullis and may be deemed to beneficially own the securities held by Tullis. Tullis Growth Partners, LLC and Tullis Growth Partners II, LLC are the general partners of Tullis Growth and Tullis Growth II, respectively, and may be deemed to beneficially own the securities held by Tullis Growth and Tullis Growth II. James L.L. Tullis is a Principal of each of the foregoing entities and may be deemed to possess voting and investment control over, and may be deemed to have an indirect beneficial ownership with respect to, the shares held by Tullis, Tullis Growth and Tullis Growth II. Read SEC document |
| July 29, 2021 Filed Jul 30, 2021 12:27 UTC |
Hooker AnaDirector
|
GrantStock Option(right to buy) · Derivative | 15,000 | $0.00 Strike: $12.28 | $0.00 |
DisclosureSEC source: 0001274737-21-000087 · wf-form4_162764802438621.xml · derivative · entry 1 Hooker Ana · CIK 0001774825 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2031-07-28 F1 · derivative.exercise_date: The option is exercisable as it vests. The total number of shares of common stock subject to the option vests in 36 equal monthly installments over the three-year period beginning on August 29, 2021, subject to the Reporting Person's continued service to the Issuer through each such vesting date. Read SEC document |
| June 29, 2021 Filed Jun 29, 2021 21:10 UTC |
TULLIS JAMES L LDirector
|
SaleCommon Stock | 5,379 | $14.67 | $78,910.47 |
DisclosureSEC source: 0000899243-21-026584 · doc4.xml · nonDerivative · entry 3 TULLIS JAMES L L · CIK 0001230641 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1,530,672 F1 · kind: These sales were effected by Tullis Growth Fund, L.P. ("Tullis Growth") pursuant to a Rule 10b5-1 trading plan adopted on March 24, 2021. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.48 to $15.04, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F5 · ownership.nature: The shares reported on this form are held of record by Tullis-Dickerson Capital Focus III, L.P. ("Tullis"), Tullis Growth and Tullis Growth Fund II, L.P. ("Tullis Growth II"). Tullis-Dickerson Partners III, LLC ("Tullis Partners") is the general partner of Tullis and may be deemed to beneficially own the securities held by Tullis. Tullis Growth Partners, LLC and Tullis Growth Partners II, LLC are the general partners of Tullis Growth and Tullis Growth II, respectively, and may be deemed to beneficially own the securities held by Tullis Growth and Tullis Growth II. James L.L. Tullis is a Principal of each of the foregoing entities and may be deemed to possess voting and investment control over, and may be deemed to have an indirect beneficial ownership with respect to, the shares held by Tullis, Tullis Growth and Tullis Growth II. Read SEC document |
| June 28, 2021 Filed Jun 29, 2021 21:10 UTC |
TULLIS JAMES L LDirector
|
SaleCommon Stock | 10,858 | $14.98 | $162,696.27 |
DisclosureSEC source: 0000899243-21-026584 · doc4.xml · nonDerivative · entry 2 TULLIS JAMES L L · CIK 0001230641 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1,536,051 F1 · kind: These sales were effected by Tullis Growth Fund, L.P. ("Tullis Growth") pursuant to a Rule 10b5-1 trading plan adopted on March 24, 2021. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.55 to $15.34, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F5 · ownership.nature: The shares reported on this form are held of record by Tullis-Dickerson Capital Focus III, L.P. ("Tullis"), Tullis Growth and Tullis Growth Fund II, L.P. ("Tullis Growth II"). Tullis-Dickerson Partners III, LLC ("Tullis Partners") is the general partner of Tullis and may be deemed to beneficially own the securities held by Tullis. Tullis Growth Partners, LLC and Tullis Growth Partners II, LLC are the general partners of Tullis Growth and Tullis Growth II, respectively, and may be deemed to beneficially own the securities held by Tullis Growth and Tullis Growth II. James L.L. Tullis is a Principal of each of the foregoing entities and may be deemed to possess voting and investment control over, and may be deemed to have an indirect beneficial ownership with respect to, the shares held by Tullis, Tullis Growth and Tullis Growth II. Read SEC document |
| June 25, 2021 Filed Jun 29, 2021 21:10 UTC |
TULLIS JAMES L LDirector
|
SaleCommon Stock | 8,763 | $16.03 | $140,503.31 |
DisclosureSEC source: 0000899243-21-026584 · doc4.xml · nonDerivative · entry 1 TULLIS JAMES L L · CIK 0001230641 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1,546,909 F1 · kind: These sales were effected by Tullis Growth Fund, L.P. ("Tullis Growth") pursuant to a Rule 10b5-1 trading plan adopted on March 24, 2021. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.74 to $16.33, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F5 · ownership.nature: The shares reported on this form are held of record by Tullis-Dickerson Capital Focus III, L.P. ("Tullis"), Tullis Growth and Tullis Growth Fund II, L.P. ("Tullis Growth II"). Tullis-Dickerson Partners III, LLC ("Tullis Partners") is the general partner of Tullis and may be deemed to beneficially own the securities held by Tullis. Tullis Growth Partners, LLC and Tullis Growth Partners II, LLC are the general partners of Tullis Growth and Tullis Growth II, respectively, and may be deemed to beneficially own the securities held by Tullis Growth and Tullis Growth II. James L.L. Tullis is a Principal of each of the foregoing entities and may be deemed to possess voting and investment control over, and may be deemed to have an indirect beneficial ownership with respect to, the shares held by Tullis, Tullis Growth and Tullis Growth II. Read SEC document |
| June 17, 2021 Filed Jun 21, 2021 08:38 UTC |
Johnson Wendy S.Director
|
GrantStock Option(right to buy) · Derivative | 9,000 | $0.00 Strike: $16.41 | $0.00 |
DisclosureSEC source: 0001274737-21-000074 · wf-form4_162427910066558.xml · derivative · entry 1 Johnson Wendy S. · CIK 0001652822 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,000 Underlying: Common Stock · 9,000 shares Expires 2031-06-16 F1 · derivative.exercise_date: The entire number of shares subject to this option becomes fully vested and exercisable on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date. Read SEC document |
| June 17, 2021 Filed Jun 21, 2021 12:38 UTC |
Nova Tina SusanDirector
|
GrantStock Option(right to buy) · Derivative | 9,000 | $0.00 Strike: $16.41 | $0.00 |
DisclosureSEC source: 0001274737-21-000075 · wf-form4_162427911766120.xml · derivative · entry 1 Nova Tina Susan · CIK 0001302605 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,000 Underlying: Common Stock · 9,000 shares Expires 2031-06-16 F1 · derivative.exercise_date: The entire number of shares subject to this option becomes fully vested and exercisable on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date. Read SEC document |
| June 17, 2021 Filed Jun 21, 2021 12:39 UTC |
Robertson Bruce CDirector
|
GrantStock Option(right to buy) · Derivative | 9,000 | $0.00 Strike: $16.41 | $0.00 |
DisclosureSEC source: 0001274737-21-000076 · wf-form4_162427913125759.xml · derivative · entry 1 Robertson Bruce C · CIK 0001289625 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,000 Underlying: Common Stock · 9,000 shares Expires 2031-06-16 F1 · derivative.exercise_date: The entire number of shares subject to this option becomes fully vested and exercisable on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date. Read SEC document |
| June 17, 2021 Filed Jun 21, 2021 12:39 UTC |
Stokes FrankDirector
|
GrantStock Option(right to buy) · Derivative | 15,000 | $0.00 Strike: $16.41 | $0.00 |
DisclosureSEC source: 0001274737-21-000077 · wf-form4_162427914687839.xml · derivative · entry 1 Stokes Frank · CIK 0001782815 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2031-06-16 F1 · derivative.exercise_date: The option is exercisable as it vests. The total number of shares of common stock subject to the option vests in 36 equal monthly installments over the three-year period beginning on July 17, 2021, subject to the Reporting Person's continued service to the Issuer through each such vesting date. Read SEC document |
| June 17, 2021 Filed Jun 21, 2021 12:39 UTC |
PALLARES EBETUELDirector
|
GrantStock Option(right to buy) · Derivative | 9,000 | $0.00 Strike: $16.41 | $0.00 |
DisclosureSEC source: 0001274737-21-000078 · wf-form4_162427916173757.xml · derivative · entry 1 PALLARES EBETUEL · CIK 0001614597 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,000 Underlying: Common Stock · 9,000 shares Expires 2031-06-16 F1 · derivative.exercise_date: The entire number of shares subject to this option becomes fully vested and exercisable on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date. Read SEC document |
| June 17, 2021 Filed Jun 21, 2021 12:38 UTC |
Birk BrianDirector
|
GrantStock Option(right to buy) · Derivative | 9,000 | $0.00 Strike: $16.41 | $0.00 |
DisclosureSEC source: 0001274737-21-000073 · wf-form4_162427908567217.xml · derivative · entry 1 Birk Brian · CIK 0001616007 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,000 Underlying: Common Stock · 9,000 shares Expires 2031-06-16 F1 · derivative.exercise_date: The entire number of shares subject to this option becomes fully vested and exercisable on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date. Read SEC document |
| June 17, 2021 Filed Jun 21, 2021 12:38 UTC |
TULLIS JAMES L LDirector · 10% owner
|
GrantStock Option(right to buy) · Derivative | 9,000 | $0.00 Strike: $16.41 | $0.00 |
DisclosureSEC source: 0001274737-21-000072 · wf-form4_162427907010300.xml · derivative · entry 1 TULLIS JAMES L L · CIK 0001230641 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,000 Underlying: Common Stock · 9,000 shares Expires 2031-06-16 F1 · derivative.exercise_date: The entire number of shares subject to this option becomes fully vested and exercisable on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date. Read SEC document |
| May 17, 2021 Filed May 17, 2021 20:06 UTC |
Hazeltine MarkChief Operating Officer
|
Exercise / conversionStock Option(right to buy) · Derivative | 1,934 | $0.26 Strike: $0.26 | $502.84 |
DisclosureSEC source: 0001274737-21-000047 · wf-form4_162129636235638.xml · derivative · entry 2 Hazeltine Mark · CIK 0001852986 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,061 Underlying: Common Stock · 2,995 shares Expires 2028-10-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option is exercisable as it vests. 25% of the shares subject to the option vested on October 5, 2019, and 1/48th of the total number of shares subject to the option vest monthly thereafter, subject to the Reporting Person's continued service to the Issuer through each such vesting date. Read SEC document |
| May 17, 2021 Filed May 17, 2021 20:06 UTC |
Hazeltine MarkChief Operating Officer
|
Exercise / conversionCommon Stock | 1,934 | $0.26 | $502.84 |
DisclosureSEC source: 0001274737-21-000047 · wf-form4_162129636235638.xml · nonDerivative · entry 1 Hazeltine Mark · CIK 0001852986 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,434 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 22:05 UTC |
Zack DebraChief Medical Officer
|
GrantStock Option(right to buy) · Derivative | 12,500 | $0.00 Strike: $18.20 | $0.00 |
DisclosureSEC source: 0001274737-21-000009 · wf-form4_161429069393025.xml · derivative · entry 2 Zack Debra · CIK 0001807743 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,500 Underlying: Common Stock · 12,500 shares Expires 2031-02-22 F3 · derivative.exercise_date: The option is exercisable as it vests. 25% of the shares subject to the option vest on February 23, 2022, and 1/48th of the total number of shares subject to the option vest monthly thereafter, subject to the Reporting Person's continued service to the Issuer through each such vesting date. In addition, the stock option may become fully vested upon a qualifying termination of employment in connection with a change in control. Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 22:05 UTC |
Zack DebraChief Medical Officer
|
GrantCommon Stock | 37,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001274737-21-000009 · wf-form4_161429069393025.xml · nonDerivative · entry 1 Zack Debra · CIK 0001807743 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,500 F1 · security: Represents restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock units will vest with respect to 25% of the restricted stock units on each of the first, second, third and fourth anniversaries of March 1, 2020, subject to the Reporting Person's continued service through the applicable vesting date. In addition, the award may become fully vested upon a qualifying termination of employment in connection with a change in control. F2 · balance_after: Represents 37,500 shares of restricted stock units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.